Cover |
Mar. 27, 2026 |
|---|---|
| Entity Addresses [Line Items] | |
| Document Type | POS AM |
| Amendment Flag | true |
| Amendment Description | This Post-Effective Amendment No. 1 to Form F-1, or Post-Effective Amendment No. 1, is being filed to update the Registration Statement on Form F-1 (Registration No. 333-291598), or the Original Registration Statement, which became effective on December 17, 2025, to incorporate by reference the Registrant’s Annual Report on Form 20-F for the fiscal year ended December 31, 2025, or the Annual Report, which was filed with the Securities and Exchange Commission on March 27, 2026. Pursuant to Rule 429 under the Securities Act, the prospectus contained in the Original Registration Statement has been combined into the prospectus contained in this Post-Effective Amendment No. 1. Accordingly, this Post-Effective Amendment No. 1 updates the Original Registration Statement. Prior to the filing of the Annual Report, the best efforts offering, or the Offering, to which the Original Registration Statement related was completed. Accordingly, this Post-Effective Amendment relates only to the exercise of the remaining Pre-funded warrants and all of the Series L warrants issued in the Offering, which are exercisable for an aggregate of 658,656,200,000 ordinary shares (underlying 6,586,562 American depositary shares, or Depositary Shares), that were issued as a component of the units in the Offering, as well as the exercise of the warrants issued to the placement agent of the Offering. No additional securities are being registered under this Post-Effective Amendment No. 1. Accordingly, this Post-Effective Amendment No. 1 concerns only the offer and sale of ordinary shares represented by Depositary Shares issuable from time to time upon exercise of such warrants that remain unexercised. All applicable registration fees were paid at the time of the original filing of the Original Registration Statement. |
| Entity Registrant Name | Biodexa Pharmaceuticals PLC |
| Entity Central Index Key | 0001643918 |
| Entity Incorporation, State or Country Code | X0 |
| Entity Address, Address Line One | 1 Caspian Point |
| Entity Address, Address Line Two | Caspian Way |
| Entity Address, City or Town | Cardiff |
| Entity Address, Postal Zip Code | CF10 4DQ |
| Country Region | +44 |
| City Area Code | 29 |
| Local Phone Number | 20480 180 |
| Entity Filer Category | Non-accelerated Filer |
| Entity Emerging Growth Company | false |
| Document Creation Date | Mar. 27, 2026 |
| Business Contact [Member] | |
| Entity Addresses [Line Items] | |
| Entity Address, Address Line One | 850 Library Ave. |
| Entity Address, Address Line Two | Suite 204 |
| Entity Address, City or Town | Newark |
| Entity Address, State or Province | DE |
| Entity Address, Postal Zip Code | 19711 |
| City Area Code | 302 |
| Local Phone Number | 738-6680 |
| Contact Personnel Name | Donald J. Puglisi |